Imgatuzumab (FUT8-KO)
Imgatuzumab (FUT8-KO) is a humanized monoclonal antibody against EGFR expressed in CHO cells with the fucosyltransferase 8 gene (FUT8) knocked out. Imgatuzumab is an immunomodulator. Imgatuzumab may be used in cancer research.
Product Specifications
Product Name Alternative
RG 7160 (FUT8-KO) ; RO 5083945 (FUT8-KO) ; Anti-EGFR Recombinant Antibody (FUT8-KO)
UNSPSC
12352005
Target
EGFR
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Smiles
[Imgatuzumab(FUT8-KO)]
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
